Table 2.
Risk scoring models for cardiac surgery-associated AKI.
| Variables | Thakar et al. [16] | Mehta et al. [18] | Wijeysundera et al. [20] | Aronson et al. [21] | Palomba et al. [19] | Brown et al. [22] | Parolari et al. [23] |
|---|---|---|---|---|---|---|---|
| Demographics | |||||||
| Age | 0 | 0 | 0 | 0 | 0 | ||
| Gender | 0 | 0 | |||||
|
| |||||||
| Baseline medical conditions | |||||||
| Hypertension | 0 | ||||||
| Pulse pressure hypertension | 0 | ||||||
| Diabetes mellitus | 0 | 0 | 0 | 0 | 0 | ||
| Preoperative renal dysfunction | 0 | 0 | 0 | 0 | 0 | 0 | |
| Congestive heart failure | 0 | 0 | 0 | ||||
| Decreased LVEF | 0 | 0 | |||||
| Advanced NYHA class | 0 | 0 | |||||
| Prior myocardial infarction | 0 | 0 | |||||
| Chronic lung disease | 0 | 0 | |||||
| Preoperative IABP | 0 | 0 | 0 | ||||
| Prior cardiac surgery | 0 | 0 | 0 | 0 | |||
| Emergency operation | 0 | 0 | |||||
| Preoperative neutrophilia | 0 | ||||||
|
| |||||||
| Intraoperative variables | |||||||
| Increased CPB time | 0 | 0 | 0 | ||||
| Two inotropes required | 0 | 0 | |||||
| Transfusion | 0 | ||||||
| Diuretics use | 0 | ||||||
|
| |||||||
| Postoperative variables | |||||||
| CVP > 14 cm H2O | 0 | ||||||
| Low cardiac output | 0 | ||||||
| Inotrope/vasoconstrictor use | 0 | ||||||
| Transfusion | 0 | ||||||
| Diuretics/antiarrhythmics use | 0 | ||||||
NYHA: New York Heart Association; CPB: cardiopulmonary bypass; CVP: central venous pressure; IABP: intra-aortic balloon pump; LVEF: left ventricular ejection fraction.